Stockscreener 앱 받기
0.9305
5.71%
0.0525
전일 마감가:
$0.878
열려 있는:
$0.85
하루 거래량:
265.23K
Relative Volume:
0.32
시가총액:
$78.55M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.5228
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
+20.13%
1개월 성능:
+22.13%
6개월 성능:
-50.37%
1년 성능:
-77.95%
1일 변동 폭
$0.8048
$0.93
1주일 범위
$0.7646
$0.9599
52주 변동 폭
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.9266 | 74.43M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.21 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.93 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.55 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
665.24 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
325.03 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Will Sutro Biopharma Inc. Benefit From Sector TailwindsQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
Volume spikes in Sutro Biopharma Inc. stock – what they meanCPI Data & Weekly Breakout Stock Alerts - Newser
Ranking Sutro Biopharma Inc. among high performing stocks via toolsJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Is Sutro Biopharma Inc. trending in predictive chart modelsWeekly Volume Report & AI Driven Price Forecasts - Newser
Detecting support and resistance levels for Sutro Biopharma Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Is Sutro Biopharma Inc. stock poised for growth2025 Volatility Report & Daily Oversold Bounce Ideas - Newser
Combining price and volume data for Sutro Biopharma Inc.2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Full technical analysis of Sutro Biopharma Inc. stockMarket Trend Review & Verified Technical Signals - Newser
Chart based analysis of Sutro Biopharma Inc. trendsMarket Movers & AI Based Trade Execution Alerts - Newser
Quantitative breakdown of Sutro Biopharma Inc. recent moveQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
Pattern recognition hints at Sutro Biopharma Inc. upside2025 Pullback Review & Real-Time Stock Price Movement Reports - Newser
Real time scanner hits for Sutro Biopharma Inc. explained2025 Earnings Surprises & Verified Technical Trade Signals - Newser
Tools to monitor Sutro Biopharma Inc. recovery probabilityStop Loss & Momentum Based Trading Signals - Newser
How to forecast Sutro Biopharma Inc. trends using time seriesQuarterly Trade Review & AI Forecast for Swing Trade Picks - Newser
Understanding Sutro Biopharma Inc.’s price movementChart Signals & Free Fast Gain Swing Trade Alerts - Newser
Visualizing Sutro Biopharma Inc. stock with heatmapsTake Profit & Risk Adjusted Buy and Sell Alerts - Newser
Has Sutro Biopharma Inc. found a price floorTrade Volume Report & High Return Stock Watch Alerts - Newser
Sutro Biopharma Inc. stock momentum explainedJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Strategies to average down on Sutro Biopharma Inc.2025 Dividend Review & Community Driven Trade Alerts - Newser
What is the target price for Sutro Biopharma Inc. stockFree Growth Stock Screener - thegnnews.com
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Real time breakdown of Sutro Biopharma Inc. stock performanceFree Day Trading Signals With High Precision - Newser
Sutro Biopharma (NASDAQ:STRO) Stock Rating Upgraded by Wall Street Zen - Defense World
Has Sutro Biopharma Inc. formed a bullish divergenceMomentum Detection with Entry Optimization - Newser
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Sutro Biopharma's Strategic Turnaround: A Path to Profitability Amidst Industry Challenges - AInvest
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase - TipRanks
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results - TipRanks
Sutro Biopharma 2025 Q2 Earnings Significant Net Loss Reduction - AInvest
SUTRO BIOPHARMA, INC. SEC 10-Q Report - TradingView
Sutro Biopharma earnings beat by $0.27, revenue topped estimates - Investing.com Canada
SUTRO BIOPHARMA Earnings Results: $STRO Reports Quarterly Earnings - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Advances Pipeline with Strategic Initiatives - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Sutro Reports 148% Revenue Growth as ADC Pipeline Expands, FDA Partnership Accelerates Development - Stock Titan
Chart overlay techniques for tracking Sutro Biopharma Inc.Low Drawdown Picks with Weekly Updates - Newser
Sutro Biopharma Inc. Inches Above Key Support — Safe to HoldConfirmed Setup With Expert Accuracy Supported - beatles.ru
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Analysts - Defense World
Using Ichimoku Cloud for Sutro Biopharma Inc. technicalsFast Return Equity Forecast With Logic - Newser
News impact scoring models applied to Sutro Biopharma Inc.Free Daily Momentum Screener With Alerts - Newser
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sutro Biopharma Inc 주식 (STRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
| NEWELL WILLIAM J | CEO |
Mar 04 '25 |
Option Exercise |
0.00 |
31,125 |
0 |
291,625 |
| Chung Jane | PRESIDENT AND COO |
Mar 04 '25 |
Option Exercise |
0.00 |
7,875 |
0 |
100,642 |
0.14%
0.30%
자본화:
|
볼륨(24시간):